Elicio Therapeutics, Inc.
ELTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,083 | -$10,561 | -$11,209 | -$14,004 |
| Dep. & Amort. | $283 | $281 | $278 | $305 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $710 | $517 | $464 |
| Change in WC | -$4,179 | -$351 | -$354 | $3,685 |
| Other Non-Cash | $2,893 | $971 | $649 | $806 |
| Operating Cash Flow | -$11,086 | -$8,950 | -$10,119 | -$8,744 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$45 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$45 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $9,866 | $0 | $0 | $0 |
| Stock Issued | -$294 | $2,016 | $10,328 | $222 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $9,916 | $0 | $5 |
| Financing Cash Flow | $9,572 | $11,932 | $10,328 | $227 |
| Forex Effect | $37 | $74 | $31 | $27 |
| Net Chg. in Cash | -$1,477 | $3,056 | $240 | -$8,535 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22,088 | $19,732 | $19,492 | $28,027 |
| End Cash | $20,611 | $22,788 | $19,732 | $19,492 |
| Free Cash Flow | -$11,086 | -$8,950 | -$10,119 | -$8,789 |